CLINICAL RESEARCH: HEART FAILURE
B-Type Natriuretic Peptide Strongly Reflects Diastolic Wall Stress in Patients With Chronic Heart Failure
Comparison Between Systolic and Diastolic Heart Failure
Yoshitaka Iwanaga, MD*,*,1,
Isao Nishi, MD*,
Shinichi Furuichi, MD*,
Teruo Noguchi, MD*,
Kazuhiro Sase, MD*,
Yasuki Kihara, MD, FACC ,
Yoichi Goto, MD* and
Hiroshi Nonogi, MD*
* Division of Cardiology, National Cardiovascular Center, Suita, Japan
Department of Cardiovascular Medicine, Kobe City General Hospital, Kobe, Japan
Manuscript received January 25, 2005;
revised manuscript received July 13, 2005,
accepted August 22, 2005.
* Reprint requests and correspondence: Dr. Yoshitaka Iwanaga, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoinn-kawaharacho, Kyoto 606-8507, Japan. (Email: yiwanaga{at}kuhp.kyoto-u.ac.jp).
OBJECTIVES: We explored the stimulus for B-type natriuretic peptide (BNP) secretion in the clinical setting of heart failure (HF).
BACKGROUND: Increasingly, plasma BNP levels are being incorporated into the clinical assessment and management of systolic heart failure (SHF) as well as diastolic heart failure (DHF). However, heterogeneity in BNP levels among individuals with HF can cause some confusion in interpreting results.
METHODS: In 160 consecutive patients presenting with HF, we measured plasma BNP levels and performed echocardiography and cardiac catheterization. Systolic and diastolic meridional wall stress was calculated from echocardiographic and hemodynamic data.
RESULTS: Although plasma BNP had a significant correlation (r2 = 0.296 [p < 0.001]) with left ventricular end-diastolic pressure (EDP) as previously reported, the correlation between plasma BNP and end-diastolic wall stress (EDWS) (r2 = 0.887 [p < 0.001]) was more robust. In a subanalysis of 62 patients with DHF, a similar result was obtained (r2 = 0.143 for EDP and r2 = 0.704 for EDWS). In a comparison between SHF and DHF, the BNP level was significantly higher in SHF (p < 0.001). Although EDP did not show any difference, EDWS was significantly higher in SHF than in DHF (p < 0.001).
CONCLUSIONS: The present study shows that plasma BNP levels reflect left ventricular EDWS more than any other parameter previously reported, not only in patients with SHF, but also in patients with DHF. The relationship of left ventricular EDWS to plasma BNP may provide a better fundamental understanding of the interindividual heterogeneity in BNP levels and their clinical utility in the diagnosis and management of HF.
|
Abbreviations and Acronyms
| | AS = aortic stenosis | | BNP = B-type natriuretic peptide | | CHF = congestive heart failure | | DHF = diastolic heart failure | | EDP = end-diastolic pressure | | EDWS = end-diastolic wall stress | | EF = ejection fraction | | HF = heart failure | | LV = left ventricle/ventricular | | LVEDVI = left ventricular end-diastolic volume index | | LVMI = left ventricular mass index | | SHF = systolic heart failure | | SWS = systolic wall stress |
|
This article has been cited by other articles:
|
|
|
|
 
P. A. McCullough and G. S. Hanzel
B-type natriuretic peptide and echocardiography in the surveillance of severe mitral regurgitation prior to valve surgery.
J. Am. Coll. Cardiol.,
September 15, 2009;
54(12):
1107 - 1109.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Madhavan, B A Borlaug, A Lerman, C S Rihal, and A Prasad
Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levels
Heart,
September 1, 2009;
95(17):
1436 - 1441.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Niizuma, Y. Iwanaga, T. Yahata, Y. Tamaki, Y. Goto, H. Nakahama, and S. Miyazaki
Impact of Left Ventricular End-Diastolic Wall Stress on Plasma B-Type Natriuretic Peptide in Heart Failure with Chronic Kidney Disease and End-Stage Renal Disease
Clin. Chem.,
July 1, 2009;
55(7):
1347 - 1353.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. R. deFilippi and R. H. Christenson
B-Type Natriuretic Peptide (BNP)/NT-proBNP and Renal Function: Is the Controversy Over?
Clin. Chem.,
July 1, 2009;
55(7):
1271 - 1273.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. W. Troughton and A. M. Richards
B-type natriuretic peptides and echocardiographic measures of cardiac structure and function.
J. Am. Coll. Cardiol. Img.,
February 1, 2009;
2(2):
216 - 225.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Niizuma, Y. Iwanaga, T. Yahata, Y. Goto, T. Kita, S. Miyazaki, and H. Nakahama
Plasma B-type natriuretic peptide levels reflect the presence and severity of stable coronary artery disease in chronic haemodialysis patients
Nephrol. Dial. Transplant.,
February 1, 2009;
24(2):
597 - 603.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. M. Hawkins, M. C. Petrie, P. S. Jhund, G. W. Chalmers, F. G. Dunn, and J. J.V. McMurray
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology
Eur J Heart Fail,
February 1, 2009;
11(2):
130 - 139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Maisel, C. Mueller, K. Adams Jr., S. D. Anker, N. Aspromonte, J. G.F. Cleland, A. Cohen-Solal, U. Dahlstrom, A. DeMaria, S. Di Somma, et al.
State of the art: Using natriuretic peptide levels in clinical practice
Eur J Heart Fail,
September 1, 2008;
10(9):
824 - 839.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Westermann, M. Kasner, P. Steendijk, F. Spillmann, A. Riad, K. Weitmann, W. Hoffmann, W. Poller, M. Pauschinger, H.-P. Schultheiss, et al.
Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection Fraction
Circulation,
April 22, 2008;
117(16):
2051 - 2060.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Grewal, R. McKelvie, E. Lonn, P. Tait, J. Carlsson, M. Gianni, C. Jarnert, and H. Persson
BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction
Eur J Heart Fail,
March 1, 2008;
10(3):
252 - 259.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kumar, A. Dispenzieri, M. Q. Lacy, S. R. Hayman, N. Leung, S. R. Zeldenrust, F. K. Buadi, R. A. Kyle, S. V. Rajkumar, and M. A. Gertz
Serum Uric Acid: Novel Prognostic Factor in Primary Systemic Amyloidosis
Mayo Clin. Proc.,
March 1, 2008;
83(3):
297 - 303.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Baumgartner
Neurohormones in valvular heart disease: what can they tell us?
Eur. Heart J.,
February 1, 2008;
29(3):
290 - 292.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. B. Daniels and A. S. Maisel
Natriuretic Peptides
J. Am. Coll. Cardiol.,
December 18, 2007;
50(25):
2357 - 2368.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kurzyna and A. Torbicki
Neurohormonal modulation in right ventricular failure
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_H):
H35 - H40.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Fijalkowska and A. Torbicki
Role of cardiac biomarkers in assessment of RV function and prognosis in chronic pulmonary hypertension
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_H):
H41 - H47.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Breidthardt, K. Laule, A.-H. Strohmeyer, C. Schindler, S. Meier, M. Fischer, A. Scholer, M. Noveanu, M. Christ, A. P. Perruchoud, et al.
Medical and Economic Long-term Effects of B-Type Natriuretic Peptide Testing in Patients with Acute Dyspnea
Clin. Chem.,
August 1, 2007;
53(8):
1415 - 1422.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. S. Redwine, P. J. Mills, S. Hong, T. Rutledge, V. Reis, A. Maisel, and M. R. Irwin
Cardiac-related Hospitalization and/or Death Associated With Immune Dysregulation and Symptoms of Depression in Heart Failure Patients
Psychosom Med,
January 1, 2007;
69(1):
23 - 29.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Nohria and M. M. Givertz
B-Type Natriuretic Peptide and the Stressed Heart
J. Am. Coll. Cardiol.,
February 21, 2006;
47(4):
749 - 751.
[Full Text]
[PDF]
|
|
|
|
